The launch of Aigisrx implantable cardioverter defibrillator (ICD) is said to extend TyRx’s Aigisrx cardiac rhythm management device (CRMD) platform to the implantable cardioverter defibrillator market.
The Aigisrx CRMD platform also includes Aigisrx PM, the company’s anti-bacterial coated mesh designed specifically for implanted pacemakers.
Bill Edelman, CEO of TyRx, said: “The launch of Aigisrx ICD offers a unique and potentially groundbreaking solution for protecting an extremely vulnerable patient population, while allowing hospitals to reduce the incidence and cost of treating surgical site infections related to ICD implantation.”